Central nervous system activity of 1-(3-methoxypropylamino)-2-hydroxy-2-(1,4-benzodioxan-2-yl)-ethane hydrochloride.
D000818:Animals; D001007:Anxiety / Q000139:chemically induced; D001522:Behavior, Animal / Q000187:drug effects; D002110:Caffeine / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004357:Drug Synergism; D004569:Electroencephalography; D006801:Humans; D008694:Methamphetamine / Q000494:pharmacology; D010624:Phenelzine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012154:Reticular Formation / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology* / Q000633:toxicity; D013874:Thiopental / Q000494:pharmacology
D013565:Sympatholytics; D002110:Caffeine; D008694:Methamphetamine; D012110:Reserpine; D013874:Thiopental; D010624:Phenelzine; D003891:Desipramine; D002746:Chlorpromazine